BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19077566)

  • 21. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.
    Vriend HJ; Bogaards JA; van Bergen JE; Brink AA; van den Broek IV; Hoebe CJ; King AJ; van der Sande MA; Wolffs PF; de Melker HE;
    Cancer Med; 2015 Oct; 4(10):1589-98. PubMed ID: 26194784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.
    Demers AA; Shearer B; Severini A; Lotocki R; Kliewer EV; Stopera S; Wong T; Jayaraman G
    Chronic Dis Inj Can; 2012 Sep; 32(4):177-85. PubMed ID: 23046799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical smear abnormalities in the United Arab Emirates: a pilot study in the Arabian Gulf.
    Ghazal-Aswad S; Gargash H; Badrinath P; Al-Sharhan MA; Sidky I; Osman N; Chan NH
    Acta Cytol; 2006; 50(1):41-7. PubMed ID: 16514839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
    Fehér E; Szalmás A
    Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chlamydia trachomatis and human papillomavirus (HPV) infections in teenage sexually active girls].
    Friedek D; Ekiel A; Romanik M; Chełmicki Z; Chełmicki A; Martirosian G
    Ginekol Pol; 2005 Nov; 76(11):879-83. PubMed ID: 16566362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of Chlamydia trachomatis in cervical smear samples with determined HPV].
    Beslagić E; Jasminka G; Mahmutović S
    Med Arh; 2004; 58(3):143-4. PubMed ID: 15484852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of lower vaginal swabs for Human papilloma virus in association with Chlamydia trachomatis infection in Cameroonian Women.
    Fogue P; Djeudong G; Bouting G; Aglago E; Simo G; Lueong S
    J Infect Public Health; 2018; 11(3):314-320. PubMed ID: 28919017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of co-infection with human papillomavirus and Chlamydia trachomatis and risk factors associated with cervical cancer in Congolese women.
    Ngombe Mouabata DFL; Boumba ALM; Massengo NRB; Pouki FS; Moukassa D; Ennaji MM
    Microbes Infect; 2024; 26(3):105287. PubMed ID: 38163457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
    Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
    J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genital tract infection with Chlamydia trachomatis in women attended at a cervical cancer screening program in Northeastern from Brazil.
    Magalhães PA; Miranda CA; Lima ÉG; Moizéis RN; de Lima DB; Cobucci RN; de Medeiros Fernandes TA; de Azevedo JC; de Azevedo PR; de Araújo JM; Fernandes JV
    Arch Gynecol Obstet; 2015 May; 291(5):1095-102. PubMed ID: 25326872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine women.
    Golijow CD; Abba MC; Mourón SA; Laguens RM; Dulout FN; Smith JS
    Gynecol Oncol; 2005 Jan; 96(1):181-6. PubMed ID: 15589598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
    Anand KV; Pimple SA; Bhattacharjee A; Mishra GA; Shastri SS
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2709-2716. PubMed ID: 34452578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulation of Human Papillomavirus and Chlamydia trachomatisin Cuban Women.
    Guilarte-García E; Soto-Brito Y; Kourí-Cardellá V; Limia-León CM; Sánchez-Alvarez ML; Rodríguez-Díaz AE; López-Fuentes LX; Méndez-González M; Aróstica-Valdés N; Bello-Pérez M; Pérez-Santos L; Pintos-Saavedra Y; Baños-Morales Y
    MEDICC Rev; 2020 Jan; 22(1):17-27. PubMed ID: 32327618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.